The chairman of the American Medical Association, Lonnie Bristow, has joined with Senator Paul Wellstone in proposing legislation to regulate the techniques used by insurers to control health costs.
Under the proposed Patient Protection Act, health plans would be required to disclose the standards used to select and exclude doctors from their networks, and doctors could appeal against exclusion. Doctors could not be dismissed from a health care network without cause, and nurses or clerks could not deny payment for a medical service; these decisions could only be made by doctors specializing in the same field as the doctor performing the service. A health plan that limited access to doctors would have to give patients a chance to see doctors outside its own network.
Patients would have the right to know whether their health plan was paying their family doctor a bonus for holding the line on expensive tests. Health plans would also be required to tell their patients upfront which treatments are covered and which are excluded, how to seek approval for expensive treatments, whether any bonuses or financial incentives for doctors could affect the quality of care, and what surveys say about consumer satisfaction with the plan. They would have to let people know if they rely on cost factors in choosing doctors.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze